Publications

Hogan Lovells Publications

Life sciences and health care horizons

Hogan Lovells Publications

Digital Health: The issues you need to consider to leverage its full potential in 2018

Technology is changing the way the healthcare industry operates, bringing huge potential for untapped business opportunity. At the same time, with these changes comes a dramatic shift in...

Hogan Lovells Publications

A data-driven era: Why digital tools are critical to life sciences players

The recent proliferation of digital health tools such as wearable remote monitoring devices and smartphone apps is leading to major changes in health management. While the streams of user...

Hogan Lovells Publications

In the EU, drug and device design can influence acceptance and pricing

Companies looking to market and sell pharmaceuticals, medical devices, or other treatment products and methods in the European Union face several different hurdles.

Hogan Lovells Publications

New Draft German Law regarding Anti-Corruption in the Healthcare Sector

The German Ministry of Justice recently provided a new draft anticorruption law explic-itly referring to the healthcare sector. This draft new law should establish a new offence of...

Hogan Lovells Publications

EU Pricing & Reimbursement Newsletter

Welcome to this special edition of the Hogan Lovells EU Pricing & Reimbursement newsletter.

Published Works

Germany's benefit assessment for medicines already in the market – an uncertain look", Regulatory Affairs Journal – Pharma (October 2013)

Published Works

Early benefit assessment and price negotiations subject to AMNOG – risks for original companies through parallel import", PharmaR, book 4 (March 2013)

;
Loading data